Synaptogenix, Inc. (SNPX)

Synaptogenix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.83	17.66	28.66	37.48	34.21	5.8
Short-Term Investments	-	-	1.44	-	-	-
Cash & Short-Term Investments	14.83	17.66	30.1	37.48	34.21	5.8
Cash Growth	-47.53%	-41.34%	-19.69%	9.54%	490.40%	-66.66%
Prepaid Expenses	0.48	0.06	0.43	1.11	1.29	0.93
Total Current Assets	15.32	17.72	30.53	38.59	35.5	6.73
Property, Plant & Equipment	0.01	0.01	0.02	0.02	0.02	0.02
Long-Term Investments	-	-	0.56	-	-	-
Total Assets	15.33	17.73	31.11	38.61	35.52	6.75
Accounts Payable	0.11	0.32	0.44	0.66	1.3	1.26
Accrued Expenses	0.1	0.7	0.44	0.54	0.7	0.35
Other Current Liabilities	-	-	3.4	0.12	-	-
Total Current Liabilities	0.21	1.01	4.28	1.31	1.99	1.61
Other Long-Term Liabilities	8.67	9.94	1.25	1.88	-	-
Total Liabilities	8.88	10.96	5.53	3.19	1.99	1.61
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	52.05	53.03	57.96	52.52	47.67	6.67
Retained Earnings	-46.89	-47.17	-33.61	-19.83	-14.14	-1.53
Comprehensive Income & Other	0.01	0.01	0	-	-	-
Total Common Equity	5.17	5.86	24.35	32.69	33.53	5.14
Shareholders' Equity	6.45	6.78	25.58	35.41	33.53	5.14
Total Liabilities & Equity	15.33	17.73	31.11	38.61	35.52	6.75
Net Cash (Debt)	14.83	17.66	30.1	37.48	34.21	5.8
Net Cash Growth	-47.53%	-41.34%	-19.69%	9.54%	490.40%	-66.66%
Net Cash Per Share	11.23	14.31	64.58	134.06	170.55	115.20
Filing Date Shares Outstanding	1.39	1.39	1.09	0.29	0.27	0.14
Total Common Shares Outstanding	1.39	1.36	0.96	0.29	0.27	0.05
Working Capital	15.11	16.71	26.26	37.27	33.51	5.12
Book Value Per Share	3.72	4.32	25.27	112.47	124.55	102.15
Tangible Book Value	5.17	5.86	24.35	32.69	33.53	5.14
Tangible Book Value Per Share	3.72	4.32	25.27	112.47	124.55	102.15

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q